PUREVAX Recombinant FeLV is the first and only recombinant canarypox-vectored nonadjuvanted feline leukemia virus (FeLV) vaccine. Safe, effective, and pure without …

Only PUREVAX ® vaccines offer a complete line of nonadjuvanted feline vaccines. PUREVAX vaccines help protect both cats and kittens from dangerous and deadly diseases, and give …

PUREVAX ® is the only fully adjuvant-free feline vaccine range and provides: Optimised safety profile with adjuvant-free protection for all components; Powerful immune response without …

Aktive Immunisierung von Katzen ab einem Alter von 8 Wochen gegen Katzenleukose zur Verhinderung einer persistenten Virämie und klinischer Symptome der damit verbundenen …

This medicine is authorised for use in the European Union. Up-to-date information on this veterinary medicinal product is available on the Veterinary Medicines Information website. …

PureVax ® Recombinant FeLV contains a non-adjuvanted lyophilized suspension of a recombinant vectored feline leukemia vaccine plus sterile water diluent. A canarypox vector …

No se ha observado ninguna interacción cuando PUREVAX ® FeLV ha sido administrada con otras vacunas felinas no adyuvadas de Boehringer Ingelheim. Restricciones de uso: Como no …

The vaccine strain is a recombinant canarypox virus expressing the env and gag genes of FeLV-A. Under field conditions, only sub-group A is infective and immunisation against sub-group A …

PUREVAX FeLV vaccine provided an equivalent degree of protection from persistent antigenemia and integration of proviral DNA as the two killed adjuvanted FeLV vaccines.

This medicine is authorised for use in the European Union. Vaccine against feline viral rhinotracheitis, feline calicivirosis, feline panleucopenia and feline leukaemia. Up-to-date …